BioPharma2 years ago
Blue Water Biotech (NASDAQ: BWV) Bolsters Commercial Presence Through Acquisition of 6 FDA-Approved Drugs
Shares of Blue Water Biotech, Inc. (NASDAQ: BWV) surged by 62.0% on Wednesday following the company’s announcement of acquiring six FDA-approved drugs across various treatment areas....